Data in Biotech
by CorrDyn
Latest episode
Blind Tests, Compliance Templates, and Design Over Prediction…
Blind Tests, Compliance Templates, and Design Over Prediction…
About this podcast
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences.
Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business.
You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter strategic decisions - at www.corrdyn.com
Episodes
The newest 20 of 81 episodes
- Blind Tests, Compliance Templates, and Design Over Prediction: Inside AION Labs · 1 h 4 min · Season 1 Episode 81Four rival pharma companies build AI startups together. The science is rarely what decides which ones succeed. You've built a model that works on public data. Now pharma wants a…
- How Twist Bioscience Synthesizes 32 Million DNA Sequences a Day for AI Drug Discovery · 46 min · Season 1 Episode 80AI can design a molecule in seconds, however someone still has to build it and test it before it means anything. You're pouring resources into AI-driven molecule design, but…
- How Standardized Cell Labeling Could Fix Biotech's Data Problem · 1 h 13 min · Season 1 Episode 79Flow cytometry can find a cell population in seconds, but naming it consistently across labs is a problem still unsolved. If you've ever tried to compare cytometry data across…
- DrugBank CEO: Why Your AI Model Is Only Giving You Half the Answer · 52 min · Season 1 Episode 78Ask a general AI model how many approved drugs hit a target, and it might tell you three when the real answer is six, sounding just as confident either way. If your team is…
- How to Identify the Blind Spots in Your Biotech's Genomic Data Before They Cost You a Drug Target · 1 h 10 min · Season 1 Episode 77Most drug discovery genomic data comes from a thin slice of the world, and that bias follows every decision downstream. Your team can run a Mendelian randomization study on…
- How to Turn Single-Cell Data Into a New Class of Cell-Depleting Therapies · 54 min · Season 1 Episode 76Why treating the cell, not the protein, could turn chronic disease treatment into something closer to a cure. You've built single-cell pipelines that spit out clusters, p-values…
- Why Biotech Talks About AI But Won't Pay for the Data It Needs · 1 h 2 min · Season 1 Episode 75Everyone in biotech agrees AI needs more data. Almost no one is willing to pay for it. If you're trying to build or buy a biotech AI model, you've hit the same wall: predictive…
- Beyond Language: Why Drug Discovery Needs Physical AI, Not Just Large Language Models · 58 min · Season 1 Episode 74In this episode of Data in Biotech, host Ross Katz sits down with Woody Sherman, Founder and Chief Innovation Officer at PsiThera, for a conversation on why AI can transform drug…
- Synthesizable by Design: Rethinking AI's Role in Small Molecule Drug Discovery · 59 min · Season 1 Episode 73In this episode of Data in Biotech, host Ross Katz sits down with Paul Finn, Chief Scientific Officer at Oxford Drug Design, for a conversation on what it actually takes to find…
- From Tissue to Mechanism to Decision: Building AI for Computational Oncology · 47 min · Season 1 Episode 72In this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a…
- Cavities in the Data: Building FDA-Cleared AI for Dental Imaging with Overjet · 59 min · Season 1 Episode 71In this episode of Data in Biotech, host Ross Katz sits down with Sadegh Salehi, Director of Research and Principal Scientist at Overjet, to explore what rigorous model…
- Data as a Moat: Why Biotech's Most Valuable Asset is Buried in a Hard Drive · 43 min · Season 1 Episode 70In this episode of Data in Biotech, host Ross Katz sits down with Jesse Johnson, founder of Merelogic, a software consulting firm specializing in data infrastructure for biotech…
- Markus Gershater on Why Experimental Design in Biotech is Broken and How to Fix It · 41 min · Season 1 Episode 2This week, we're delighted to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life…
- Data Science and Diagnostic Models - the What, Why and How with Michelle Wiest · 44 min · Season 1 Episode 3This week, we're delighted to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect…
- The Patient is Not a Document: Foundation Models for Biomedical AI with Standard BioModel · 50 min · Season 1 Episode 69In this episode of Data in Biotech, host Ross Katz sits down with Kevin Brown, co-founder of Standard BioModel, to explore one of the most ambitious projects in biomedical AI…
- Physics, Free Energy, & Drug Discovery: Inside Schrödinger's Computational Platform · 58 min · Season 1 Episode 68In this episode of Data in Biotech, Ross Katz sits down with Robert Abel, Chief Scientific Officer of the Platform at Schrödinger, to explore how physics-based computational…
- AI in biotech: separating hype from reality with Ben Locwin · 30 min · Season 1 Episode 67In this episode of Data in Biotech, host Ross Katz sits down with Ben Locwin, Vice President at Reliant Life Sciences, to explore the evolving landscape of artificial…
- 3D Printing Therapeutics at Scale with Aprecia Pharmaceuticals · 49 min · Season 1 Episode 66In this episode of Data in Biotech, Ross Katz sits down with Kyle Smith and Jacob Mayer from Aprecia Pharmaceuticals to explore how 3D printing is transforming pharmaceutical…
- Success-Driven Drug Discovery with OpenBench CEO James Yoder · 54 min · Season 1 Episode 65In this episode of Data in Biotech, host Ross Katz sits down with James Yoder, Founder and CEO of OpenBench, to unpack a radical new approach to early-stage drug discovery. James…
- Brant Peterson on Valo Health’s patient-first approach to drug discovery · 53 min · Season 1 Episode 64Brant Peterson, Vice President & Fellow at Valo Health, joins Data in Biotech to explore how his team leverages real-world data, genetic insights, and machine learning to de-risk…
